Kris Van Moer
Impact in
- Physiology top 2%
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
Papers in
- Immunology 15
- Immune cells in cancer 6
- Immune Cell Function and Interaction 5
- Immunotherapy and Immune Responses 3
-
- RNA modifications and cancer 3
- Co-authors
- Bassam Janji (20 shared papers)Guy Berchem (20 shared papers)Muhammad Zaeem Noman (13 shared papers)Salem Chouaı̈b (10 shared papers)Elodie Viry (5 shared papers)Etienne Moussay (7 shared papers)Tsolère Arakelian (4 shared papers)Meriem Hasmim (6 shared papers)
- Journals
- OncoImmunology (3 papers)Proceedings of the National Academy of Sciences (3 papers)Cancer Research (2 papers)Journal of Biological Chemistry (2 papers)Frontiers in Immunology (2 papers)
- Partner nations
- LuxembourgFranceBelgium
In The Last Decade
Kris Van Moer
25 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 95
- Physiology 169
- Cancer Research 491
- Immunology 600
- Epidemiology 532
- Oncology 419
Countries citing papers authored by Kris Van Moer
This map shows the geographic impact of Kris Van Moer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kris Van Moer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kris Van Moer more than expected).
Fields of papers citing papers by Kris Van Moer
This network shows the impact of papers produced by Kris Van Moer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kris Van Moer. The network helps show where Kris Van Moer may publish in the future.
Co-authors
The 25 scholars most cited alongside Kris Van Moer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 278 | |
| 2 | 2011 | 204 | |
| 3 | 2020 | 194 | |
| 4 | 2017 | 182 | |
| 5 | 2011 | 140 | |
| 6 | 2021 | 101 | |
| 7 | 2011 | 101 | |
| 8 | 2019 | 90 | |
| 9 | 2015 | 84 | |
| 10 | 2009 | 73 | |
| 11 | 2010 | 70 | |
| 12 | 2017 | 65 | |
| 13 | 2008 | 58 | |
| 14 | 2016 | 52 | |
| 15 | 2011 | 49 | |
| 16 | 2010 | 40 | |
| 17 | 2021 | 26 | |
| 18 | 2009 | 20 | |
| 19 | 2022 | 13 | |
| 20 | 2014 | 13 |
About Kris Van Moer
Kris Van Moer is a scholar working on Immunology, Molecular Biology, Epidemiology, Cancer Research and Oncology, having authored 26 papers that have together received 1.9k indexed citations. Recurring topics across this work include Autophagy in Disease and Therapy (8 papers), Immune cells in cancer (6 papers), Immune Cell Function and Interaction (5 papers), Cancer, Hypoxia, and Metabolism (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), Immunotherapy and Immune Responses (3 papers), RNA modifications and cancer (3 papers) and Cancer-related molecular mechanisms research (3 papers). The work is most often cited by research in Physiology (169 citations), Cancer Research (491 citations), Immunology (600 citations), Epidemiology (532 citations) and Oncology (419 citations). Kris Van Moer has collaborated with scholars based in Luxembourg, France and Belgium. Frequent co-authors include Bassam Janji, Guy Berchem, Muhammad Zaeem Noman, Salem Chouaı̈b, Elodie Viry, Etienne Moussay, Tsolère Arakelian, Meriem Hasmim, Sandrine Pierson and Malina Xiao. Their work appears in journals such as OncoImmunology, Proceedings of the National Academy of Sciences, Cancer Research, Journal of Biological Chemistry and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.